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Dendritic cells (DCs) are key players in the immune
system. Much of their biology has been elucidated
via culture systems in which hematopoietic precur-
sors differentiate into DCs under the aegis of cyto-
kines. A widely used protocol involves the culture of
murine bone marrow (BM) cells with granulocyte-
macrophage colony-stimulating factor (GM-CSF) to
generate BM-derivedDCs (BMDCs). BMDCs express
CD11c andMHCclass II (MHCII)molecules and share
with DCs isolated from tissues the ability to present
exogenous antigens to T cells and to respond to
microbial stimuli by undergoing maturation. We
demonstrate that CD11c+MHCII+ BMDCs are in fact
a heterogeneous group of cells that comprises con-
ventional DCs and monocyte-derived macrophages.
DCs and macrophages in GM-CSF cultures both
undergo maturation upon stimulation with lipopoly-
saccharide but respond differentially to the stimulus
and remain separable entities. These results have
important implications for the interpretation of a
vast array of data obtained with DC culture systems.
INTRODUCTION
Dendritic cells (DCs) are sentinel leucocytes that reside in tissues
and respond to pathogen entry by undergoing ‘‘maturation’’ and
becoming competent to prime T cell responses (Banchereau and
Steinman, 1998; Merad et al., 2013). DCs have traditionally been
defined by phenotypic as well as functional characteristics. The
former includes lack of expression of lineage-restricted markers
and expression of the integrin CD11c and MHC class II (MHCII)
molecules. Functional attributes include high motility and the
ability to efficiently capture, process, and present antigens to T
lymphocytes. This definition has become blurred of late by ana-
lyses that have underscored a marked degree of overlap be-
tween DCs and macrophages, including the ability of the latterto sometimes express MHCII and/or CD11c (Merad et al.,
2013). It has prompted a move to distinguish members of the
mononuclear phagocyte family on the basis of a different crite-
rion, that of ontogeny (Guilliams et al., 2014). This notion comes
from recent work demonstrating that the differentiation of DCs is
distinct from that of macrophages (Guilliams et al., 2014; Hoeffel
et al., 2012; Meredith et al., 2012; Satpathy et al., 2012; Schraml
et al., 2013). Indeed, DCs develop from a common DC precursor
(CDP) (Naik et al., 2007; Onai et al., 2007) via an intermediate cell
stage known as the pre-DC (Ginhoux et al., 2009; Liu et al., 2009).
In contrast, macrophages develop from embryonic precursors
(Ginhoux et al., 2010; Hoeffel et al., 2012; Schulz et al., 2012).
Cells that resemble DCs or macrophages can also be derived
from monocytes and traditionally have been called monocyte-
derived DCs or monocyte-derived macrophages, respectively
(Bain et al., 2014; Mildner et al., 2013; Tamoutounour et al.,
2013), although it has recently been proposed that they be
generically termed monocyte-derived cells (MCs) (Guilliams
et al., 2014). Monocytes themselves have been shown to
descend from a common monocyte precursor (cMoP) (Hettinger
et al., 2013), and both CDPs and cMoPs can be generated from a
macrophage-DC progenitor (MDP) population (Fogg et al., 2006;
Hettinger et al., 2013; Liu et al., 2009). Thus, one can define clas-
sical DCs as cells that descend from CDPs and pre-DCs irre-
spective of phenotype or function (Guilliams et al., 2014). We
have recently provided experimental support for this concept
by taking advantage of the fact that CDPs and pre-DCs express
DNGR-1 (also known as CLEC9A). We generated Clec9acreRo-
saEYFP reporter mice in which the Clec9a locus control regions
drive Cre expression in DNGR-1+ cells, allowing for a recombina-
tion event that irreversibly traces CDPs and pre-DCs progeny
(Schraml et al., 2013). In these mice, DCs can be reliably identi-
fied and distinguished from macrophages and MCs by YFP re-
porter gene expression (Schraml et al., 2013).
The ontogenetic approach to DC definition has been comple-
mented by identification of core DC and macrophage gene
expression signatures that permit reliable separation of the two
cell types (Gautier et al., 2012; Miller et al., 2012). This has been
madepossibleby systematic efforts tocharacterizegeneexpres-
sion profiles of mouse tissue leukocyte populations, notably by
the Immgen consortium, and has greatly expanded theImmunity 42, 1197–1211, June 16, 2015 ª2015 Elsevier Inc. 1197
phenotypic method of cell classification (Heng et al., 2008).
Global description of gene expression profiles further permits
analysis of relationships among leukocytes through unsuper-
vised hierarchical data clustering. Suchmethodology has offered
new insight into the biology of macrophages, MCs, and DCs. For
example, it revealed that DCs migrating from peripheral tissues
into lymph nodes cluster together independently of tissue of
origin, indicating that they adopt a common program of differen-
tiation (Miller et al., 2012). Thus, ontogeny and global gene
expression analysis constitute powerful new approaches with
which to dissect the heterogeneity of the mononuclear phago-
cyte system and better define DCs, MCs, and macrophages.
Because of their rarity in tissues, much of the biology of DCs
has been surmised from studies of cells grown in vitro from he-
matopoietic precursors under the influence of growth factors
(Caux et al., 1992; Inaba et al., 1992; Naik et al., 2007; Palucka
et al., 1998; Sallusto and Lanzavecchia, 1994). In particular,
the culture of mouse BM cells with GM-CSF, a cytokine involved
in the development and homeostasis of mononuclear phago-
cytes, has been used extensively to generate CD11c+MHCII+
cells that resemble tissue DCs and are often termed BMDCs
(Inaba et al., 1992; Lutz et al., 1999). The output from GM-CSF
cultures is heterogeneous and comprises granulocytes and
macrophages in addition to DCs. The latter are reported to be
enriched in the loosely adherent culture fraction and to express
CD11c and MHCII whereas macrophages are thought to be
adherent and negative for CD11c and MHCII (Inaba et al.,
1992). As such, many laboratories commonly employ magneti-
cally enriched or FACS-sorted CD11c+ loosely adherent and
non-adherent cells as a source of pure BMDCs. Gene expression
analysis studies of such cells have assumed that this DC popu-
lation is homogeneous and that any cell-to-cell variation is the
result of different states of DC maturation (Shalek et al., 2013,
2014; Vander Lugt et al., 2014). However, the ontogenetic origin
of BMDCs is uncertain and, in fact, Ly6C+monocytes rather than
CDPs have been suggested to act as precursors (Mayer et al.,
2014; Xu et al., 2007). As such, it is unclear howGM-CSF-derived
BMDCs fit within the recent framework of defining DCs by onto-
genetic criteria. Here, we show that CD11c+MHCII+ cells in
BMDC cultures are in fact heterogeneous in terms of hematopoi-
etic origin and gene expression profiles. They encompass at
least two distinct populations that derive from either a monocytic
or a DC myelopoietic branch and that display distinct immune
functions in vitro and in vivo. On the basis of ontogenetic,
morphological, and gene expression criteria, we classify these
two populations as bona fide DCs and monocyte-derived mac-
rophages. We further show that they both undergo maturation
in response to lipopolysaccharide (LPS) yet mount distinct re-
sponses to the stimulus and remain separable entities. These
findings have implications for the interpretation of numerous
studies employing GM-CSF-derived BMDCs as a cell model.
RESULTS
Phenotypic Heterogeneity of GM-CSF-Derived
CD11c+MHCII+ BMDCs
To a variable extent, CD11c+MHCII+ cells fromGM-CSF cultures
often present as two sub-populations, one that is believed to
represent an immature DC phenotype with intermediate or low1198 Immunity 42, 1197–1211, June 16, 2015 ª2015 Elsevier Inc.expression of MHCII and co-stimulation molecules such as
CD40 and CD86 (Figure 1A, blue) and another that has under-
gone spontaneous maturation and expresses higher amounts
of the same markers (Figure 1A, red). However, the transcription
factor IRF4 was recently argued to control the development of
BMDCs falling within the mature gate, as well as the develop-
ment of a subset of tissue-resident conventional CD11b+ DCs
inmouse small intestine, lung, and spleen (Gao et al., 2013; Pers-
son et al., 2013; Schlitzer et al., 2013; Vander Lugt et al., 2014). It
is therefore possible that the heterogeneous phenotype of
BMDCs could reflect the presence of different cell subsets rather
than, or in addition to, distinct maturation states. Accordingly,
CD11c+MHCIIhi mature BMDCs expressed higher amounts of
CD24, DEC205, PD-L2, and IRF4 (Figure 1B, red), whereas
CD11c+MHCIIint immature BMDCs displayed higher expression
of SIRPa, F4/80, and CD11b (Figures 1A and 1B, blue), all
markers that can to some extent distinguish subtypes of DCs
andmacrophages. Themature BMDC subset expressed surface
markers generally restricted to DCs (CD135, CCR7, CD117)
whereas immature BMDCs expressed higher amounts of
markers often associated with monocytes and macrophages
(CD64, CD115, CD14) (Figure 1C). In line with these results,
Zbtb46 and MerTK, two genes whose expression is argued to
mark DCs versus macrophages, respectively (Gautier et al.,
2012; Meredith et al., 2012; Miller et al., 2012; Satpathy et al.,
2012), were expressed by either the mature or the immature
BMDC fractions (Figure 1D). The two BMDC populations could
not be distinguished by their differential adhesion to plastic
although mature cells were more highly represented in the
non-adherent floating cell fraction (Figure 1E). Altogether, these
results began to suggest that two types of loosely adherent
CD11c+MHCII+ mononuclear phagocytes might arise in GM-
CSF BM cultures, a mature one similar to DCs and an immature
one resembling macrophages.
Different Hematopoietic Progenitors Expand in GM-CSF
Cultures to Give Rise to CD11c+MHCII+ Progeny
To further address this issue, we probed the hematopoietic
origin of CD11c+MHCII+ BMDCs. We purified populations of
MDPs, CDPs, cMoPs, and monocytes (see Experimental Proce-
dures) from the BM of CD45.2 C57BL/6 mice and co-cultured
them with unfractionated BM cells (filler cells) from a CD45.1
congenic strain for 6 days with GM-CSF. The filler cells acted
as a source of growth factors and an internal control for BMDC
generation (data not shown). Analysis of the CD45.2+ output
from the cultures revealed that all precursors were able to
expand in GM-CSF cultures and generate CD11c+MHCII+ cells
albeit to a variable extent (Figures 2A and 2B). MDPs and cMoPs
expanded vigorously and gave rise to both MHCIIhiCD11bint and
MHCIIintCD11bhi cells (Figures 2A and 2B), which could also be
distinguished on the basis of CD24 and SIRPa expression (Fig-
ure 2C). The same was true for Ly6Chi and Ly6Clo monocytes
although those cells expanded only poorly (Figures 2A and 2B).
We could not phenotypically distinguish between MHCIIhi
CD11bint cells derived from cMoPs versus those developing
from Ly6Chi monocytes, suggesting a common developmental
pathway (Figure S1). In contrast, CDPs expanded modestly but
preferentially gave rise to MHCIIhiCD11bintCD24hiSIRPaint cells
(Figures 2A–2C). Similarly, when CDPswere purified on the basis
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Figure 1. Phenotype of Cells Developing in GM-CSF BM Cultures
(A–C) Phenotype of representative GM-CSF BM cultures at day 6. CD11c+MHCII+ BMDCs (A, left) can be sub-divided on the basis of CD11b and MHCII
expression (A, right). Boxes depict gates and numbers correspond to percentage of cells in each gate. Histograms showing surface expression of the indicated
markers by MHCIIhiCD11blo (red) and MHCIIintCD11bhi (blue) subsets. Filled histograms represent isotype-matched irrelevant specificity controls.
(D) Quantitative PCR for Zbtb46 andMerTK transcripts in cDNA from sortedMHCIIhi (red) andMHCIIint (blue) subsets. Data representmean ± SD of triplicate wells
from one representative experiment.
(E) Flow cytometry analysis of BMDC subsets in loosely adherent versus non-adherent fractions of the GM-CSF culture. Boxes depict gates and numbers
correspond to percentage of cells in each gate. Data are representative of at least three experiments.
Immunity 42, 1197–1211, June 16, 2015 ª2015 Elsevier Inc. 1199
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Figure 2. Precursors of Both Monocytes and
Dendritic Cells Develop into CD11c+MHCII+
Cells in GM-CSF Cultures
(A) 104 of the indicated CD45.2+ progenitors and 106
CD45.1 total BM filler cells were co-cultured in the
presence of GM-CSF for 6 days. Data show relative
proportion of CD45.1 and CD45.2 cells and
expression of CD11c, MHCII, and CD11b on
CD45.2+ cells before or after gating on CD11c+
MHCII+ cells. Boxes depict gates and numbers
correspond to percentage of cells in each gate. Data
are representative of four experiments.
(B) Analysis of CD45.2+ cells showing calculated
fold-increase in cellularity over input, percentage of
CD11c+MHCII+ cells amongCD45.2+ cells, and ratio
of MHCIIhi to CD11bhi cells among CD45.2+
CD11c+MHCII+ cells. Each symbol represents the
average of two to three replicates from a single
experiment. The bar represents the mean. Four
pooled independent experiments are shown.
(C) Analysis of CD24 and SIRPa expression on
CD45.2+CD11c+MHCII+ subsets derived from the
indicated precursors.
(D) 104 CD45.2+ YFP+ cells isolated by cell sorting
from the BM of Clec9acre/creRosaWT/EYFP mice were
co-cultured for 6 days in GM-CSF with 106 CD45.1
total BM filler cells. Data depict flow cytometry
analysis of the progeny of CD45.2+ progenitors
according to the expression of CD11c, MHCII, and
CD11b.
(E) Flow cytometry analysis of YFP, CD11c, MHCII,
CD11b expression on day 6 GM-CSF cultures of BM
of Clec9acre/creRosaWT/EYFP mice.
In (C)–(E), boxes depict gates, arrows show gating
hierarchy, and numbers correspond to percentage
of cells in each gate. Data are representative of four
experiments. See also Figure S1.
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of YFP expression from Clec9acre/creRosaWT/EYFP mice (Schraml
et al., 2013), their progeny was exclusively found among
CD11c+MHCIIhiCD11bint cells (Figure 2D). GM-CSF cultures of
total BM cells from the same reporter mice revealed that YFP+
progeny of CDPs was highly enriched within the MHCIIhi fraction
of CD11c+ cells, in contrast to YFP– cells, which distributed be-
tween CD11c– and CD11c+MHCIIhi and CD11c+MHCIIlo gates
(Figure 2E). Together, these data suggest that the MHCIIhi
CD11bint population of BMDCs includes both cells derived
from CDPs and cells of similar phenotype but derived from
cMoPs and monocytes. The MHCIIintCD11bhi fraction, in
contrast, consists primarily of cells derived from cMoPs and
monocytes.
CD11c+MHCII+ BMDCs Comprise Cells Resembling
Conventional DCs or Macrophages
In an effort to further distinguish cells of different origin, we
assessed their expression of CD115 and CD135, receptors for
M-CSF and Flt3L, which are necessary for the differentiation of
monocyte-derived macrophages and DCs, respectively (Gin-
houx et al., 2006, 2009;McKenna et al., 2000; Pixley and Stanley,
2004). CD135+ cells were found only among MHCIIhiCD11bint
cells and could be derived fromCDP but not cMoP fractions (Fig-
ures 3A and 3B). In contrast, CD115+ cells were found in both
MHCIIintCD11bhi and MHCIIhiCD11bint fractions and were pri-
marily derived from cMoPs with only a small contribution from
CDPs (Figures 3A and 3B). MDPs gave rise to both CD135+
and CD115+ cells (Figures 3A and 3B). These results suggest
that CD115 and CD135 can be used to identify the two develop-
mentally distinct CD11c+MHCII+ mononuclear phagocytes in
GM-CSF mouse bone marrow cultures. We therefore designed
a gating strategy to purify these subsets from bulk BMDC cul-
tures (Figure 3C). cMoP-derived cells, resembling monocyte-
derived macrophages, were defined as CD11c+MHCIIintCD115+
MerTK+ whereas CDP-derived cells, resembling conventional
DCs, were defined as CD11c+MHCIIhiCD115–CD135+ cells (Fig-
ure 3C). For the purpose of clarity, we will henceforth refer to
these sub-populations as GM-Macs and GM-DCs, respectively,
although it should be remembered that both are CD11c+MHCII+
and have historically been termed BMDCs.
A large fraction of CD11c+MHCIIhi cells from bulk cultures did
not express either CD115 or CD135 and were ostensibly neither
GM-DCs nor GM-Macs (Figure 3C). When purified by cell sorting
and cultured for an extra 3 days in medium with GM-CSF, some
of these double-negative cells (GM-DN) upregulated CD135 but
not CD115 and became similar to GM-DCs (Figure 3D). How-
ever, a proportion of re-cultured GM-DN cells remained CD135
negative, perhaps reflecting those that originated from cMoPs
and monocyte precursors (see Figure 3A). In contrast to GM-
DN cells, GM-Macs and GM-DCs had a stable phenotype and
remained discrete populations even after purification and re-
culture for 3 days in GM-CSF medium (Figure 3D). Therefore,
we focused subsequent analyses on these populations given
their stability and relative homogeneity, although in some but
not all settings, we analyzed GM-DN cells in parallel.
Interleukin-4 (IL-4) has sometimes been added to GM-CSF
BM cell cultures to generate BMDCs (Lu et al., 1995; Son
et al., 2002; Xu et al., 2007). We therefore investigated the
phenotype and hematopoietic origin of BMDCs cultured in thepresence of bothGM-CSF and IL-4. AmongCD11c+MHCII+ cells
arising in GM-CSF + IL-4 culture, two populations could be
distinguished using MHCII and CD11b expression (Figure 4A).
The MHCIIintCD11bhi cells expressed CD115 and MerTK
whereas the MHCIIhiCD11bint cells did not and some expressed
CD135. Similar to GM-CSF-only cultures, all mononuclear
phagocyte precursors expanded and differentiated into CD11c+
MHCII+ cells in GM-CSF + IL-4 cultures. cMoPs expanded to a
greater degree than other precursors (Figure 4B). These results
suggest that IL-4 does not prevent the development of mono-
cyte-derived macrophages and underscore the notion that
CD11c+MHCII+ BMDCs are a heterogeneous cell population.
Distinct Functions of GM-Macs and GM-DCs
We compared the behavior of GM-Macs and GM-DCs. GM-
Macs had a typical macrophage morphology and were largely
immotile (Figure 5A andMovie S1). They produced high amounts
of interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-a), che-
mokine (C-X-C motif) ligand 1 (CXCL1), chemokine (C-C motif)
ligand 3 (CCL3), chemokine (C-C motif) ligand 5 (CCL5), and
interleukin 12 B subunit (IL-12p40) in response to microbial
stimuli (Figure 5B), expressed C-C chemokine receptor type 2
(CCR2, data not shown), andmigrated in response to the chemo-
kine (C-C motif) ligand 2, CCL2 (Figure 5C). In contrast, GM-DCs
were very motile and continuously extended and retracted den-
dritic processes (Figure 5A and Movie S2). They produced low
amounts of inflammatory cytokines and chemokines in response
to microbial stimuli (Figure 5B), expressed C-C chemokine re-
ceptor type 7 (CCR7, data not shown), and migrated in response
to the CCR7 ligand, chemokine (C-C motif) ligand 21 (CCL21)
(Figure 5C). We next analyzed the capacity of each subset to
stimulate naive OT-II CD4+ T cells specific for the model antigen
ovalbumin (OVA). When given pre-processed antigenic peptide,
both GM-DCs and GM-Macs displayed comparable ability to
stimulate OT-II T cell division and expansion in culture (Fig-
ure 5D). The stimulatory ability was not prominently changed
by stimulation of the cells with LPS, which is commonly em-
ployed to induce DC ‘‘maturation’’ (Figure 5D). In contrast,
when given OVA protein, GM-Macs were markedly inferior at
stimulating OT-II when compared to GM-DCs, even after LPS
stimulation (Figure 5D), despite the fact that they accumulated
more antigen by endocytosis (Figure S2). This was most patent
at the level of T cell expansion in culture, whichwas 15-fold lower
when GM-Macs rather than GM-DCs were used as antigen-pre-
senting cells (APCs) (Figure 5D). We then examined the ability of
either APC subset to stimulate OT-I CD8+ T cells in analogous
assays. BothGM-DCs andGM-Macswere able to cross-present
OVA protein as measured by induction of OT-I proliferation but
only T cells primed by GM-DCs upregulated CD25 (Figure 5E).
Notably, GM-Macs were less efficient at inducing expression
of CD25 in OT-I cells even when given pre-processed OVA pep-
tide and stimulated with LPS (Figure 5E, right). Therefore, the
inferior capacity of GM-Macs to stimulate OT-I cells is intrinsic
to the cells and not merely attributable to decreased cross-pre-
sentation ability. In view of these data, we assessed the ability of
each BMDC subset to prime anti-tumor cytotoxic T cells (CTLs)
upon infusion into mice. Low numbers of GM-DCs pulsed with
OVA peptide were able to induce an anti-OVA CTL response
(Figure 5F, left), which was sufficient to protect mice fromImmunity 42, 1197–1211, June 16, 2015 ª2015 Elsevier Inc. 1201
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Figure 3. CD11c+MHCII+ BMDCs Comprise Cells Resembling Conventional DCs or Macrophages
(A) CD115 and CD135 expression on CD45.2+CD11c+MHCII+ subsets derived from the indicated precursors and pre-gated as in Figure 2A. Boxes depict gates
and numbers correspond to percentage of cells in each gate. Data are representative of three experiments.
(B) Percentage of CD11c+MHCII+ cells expressing either CD115 or CD135 as in (A). Each symbol corresponds to an individual replicate from a pool of four
independent experiments. The bar represents the mean.
(C) Flow cytometric definition of GM-DCs, GM-DNs, and GM-Macs from GM-CSF BM cultures. Data depict the total non-adherent and loosely adherent fraction
of 6 days GM-CSF BM cultures gated from left to right as indicated.
(D) GM-DCs, GM-DNs, and GM-Macs were FACS sorted at day 6 of GM-CSF BM culture and plated again in 96-well plates with GM-CSF. After 3 days of culture,
expression of CD115 and CD135 was measured by flow cytometry. Boxes depict gates and numbers correspond to percentage of cells in each gate. Data are
representative of three experiments.
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Figure 4. IL-4 Addition Limits but Does Not
Prevent Development of Typical GM-Macs
(A) BM cells were cultured with GM-CSF ± IL-4. At
day 6, cells were harvested and the expression of
CD11c, CD11b, MHCII, CD135, MerTK, and
CD115 was analyzed by flow cytometry.
(B) Analysis of the progeny of the indicated
CD45.2+ progenitors upon culture in GM-CSF +
IL-4. See Figure 2 for experimental details.
Boxes depict gates and numbers correspond to
percentage of cells in each gate. Data are repre-
sentative of three experiments.subsequent challenge with OVA-expressing B16.F10 melanoma
cells (Figure 5F, right). In contrast, around 10-fold higher
numbers of GM-Macs were required to elicit the same degree
of CTL priming and degree of anti-tumor protection (Figure 5F).
The failure of GM-Macs to efficiently induce CTL responses
probably reflects their inferior capacity to prime CD8+ T cells
coupled to inability to migrate to secondary lymphoid organs in
response to CCR7 ligand gradients.
In one series of experiments, we also assessed the functional
behavior of GM-DN cells. Despite the fact that they are ontoge-
netically heterogeneous (see Figures 2 and 3), they were found to
resemble GM-DCs, displaying similar morphology (Figure S3A),
equivalent capacity to migrate toward CCL21 but not CCL2 (Fig-
ure S3B), and corresponding ability to process OVA and effi-
ciently prime CD4+ and CD8+ naive T cells in vitro (Figures S3C
and S3D). Altogether, these results indicate that CD11c+MHCII+
BMDCs comprise both motile DCs with superior T cell priming
ability and sessile macrophages with marked ability to produce
inflammatory mediators in response to innate immune stimuli.Immunity 42, 1197–121The two types of cells display some over-
lap in phenotype and function, which can
be further affected by prior stimulation, for
example with LPS.
GM-DC and GM-Macs Express DC
and Macrophage Signature Genes
Microarray analysis of CD11c+MHCII+
subsets revealed that macrophage signa-
ture genes and a small proportion of DC
signature genes are enriched in GM-
Macs and the remainder of DC signature
genes but not macrophage signature
genes are enriched in the GM-DC subset
(Figure 6A). Nevertheless, GM-DCs did
not uniformly express all the genes that
comprise the DC signature. To evaluate
the significance of this discrepancy, we
analyzed the expression of DC signature
genes in four other DC subsets profiled
in the Immgen database (Figure S4A).
We found that variation in expression of
DC signature genes is in fact also seen
across DC subsets isolated directly from
tissues and is therefore a reflection of nat-
ural variation in DC gene expression pat-terns. Using the DC and macrophage gene signatures, we then
performed an unsupervised hierarchical clustering of GM-DCs
and GM-Macs with DC and macrophage populations from the
Immgen database (Figures S5A and S5B). This confirmed that
GM-DCs clusteredwith DC populations andGM-Macs clustered
with macrophage populations. To assess whether maturation
overrides these differences and leads to acquisition of a com-
mon gene expression signature, we exposed the subsets to
LPS. We found that both GM-Macs and GM-DCs behaved simi-
larly with regards to surface expression of CD11c, CD86, and
MHCII (Figure 6B) and upregulation of expression of genes char-
acteristic of maturation and LPS response (Figure 6C). Neverthe-
less, principal-component analysis (PCA) of the expression of all
genes revealed that LPS-stimulated GM-Macs clustered with
their unstimulated counterparts rather than with GM-DCs (Fig-
ure 6D). Likewise, stimulated GM-DCs clustered with unstimu-
lated GM-DCs rather than stimulated GM-Macs (Figure 6D).
Similar results were obtained when PCA was restricted to
expression of the DC and macrophage core signature genes1, June 16, 2015 ª2015 Elsevier Inc. 1203
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(Figures 6E and 6F). These results confirm that GM-Macs and
GM-DCs are distinct populations and show that they remain
separate entities after undergoing maturation.
To further explore this issue, we performed a Venn diagram
analysis and found that GM-DC and GM-Macs display differen-
tial responses to LPS with only 794 genes regulated in common
and 783 versus 2,469 genes up- or downregulated selectively in
GM-DCs versus GM-Macs, respectively (Figure 6G). Among the
genes highly expressed in LPS-stimulated GM-DCs were ones
encoding typical maturation markers (Figure 6H), which never
quite reached the same level of expression in GM-Macs (Fig-
ure 6C), despite being greatly upregulated in the latter cells. In
contrast, many interferon-stimulated genes were more highly
expressed in LPS-stimulated GM-Macs than in GM-DCs
(Figure 6H).
In Vivo Equivalence of GM-DCs and GM-Macs
Finally, we analyzed the gene expression patterns of unstimu-
lated and LPS-stimulated GM-DCs and GM-Macs to identify
their closest relatives in vivo by reference to the Immgen data-
base. We first performed unsupervised hierarchical clustering
of the transcriptome of GM-DCs and that of DCs isolated from
various organs (Figure 7A). We found that GM-DCs, although
distinct from all other DC types, clustered most closely with
migratory DCs (Miller et al., 2012) (Figure 7A) and expressed
manymigratory DC signature genes (Figure 7B), as recently sug-
gested for ‘‘mature BMDCs’’ generated with GM-CSF and IL-4
(Vander Lugt et al., 2014). Accordingly, GM-DCs might consti-
tute a useful in vitro model to study the properties of migratory
DCs. To evaluate the relationship between GM-DCs and the
two major classical DC subsets, we analyzed the expression of
genes specific to the CD8a+ and CD8a DC families (Balan
et al., 2014; Mayer et al., 2014). GM-DCs did not appear to
belong to either DC subset (Figure S6). However, their develop-
ment appears to be controlled by IRF4 (Gao et al., 2013), so GM-
DCs might be more closely related to the CD8a DC family,
perhaps consistent with their expression of CD11b and SIRPa.
We then performed the same unsupervised hierarchical clus-
tering for GM-Macs. GM-Macs clustered separately from other
macrophages, with their closest relatives being alveolar macro-
phages, splenic red pulp macrophages, and peritoneal macro-
phages (Figure 7C). Consistent with that notion, GM-Macs
expressed some of the genes also found in those three popula-Figure 5. GM-DCs and GM-Macs Have Distinct Phenotype and Functio
(A) Morphology of GM-DCs and GM-Macs. See also Movies S1 and S2.
(B) GM-DCs and GM-Macs were cultured with the indicated stimuli. Accumulatio
after 24 hr.
(C) Differential response of GM-DCs and GM-Macs to CCR7 and CCR2 agonists
(D) Stimulation of CD4+ T cells. GM-DCs and GM-Macs were incubated with OVA
labeled naive CD4+ OT-II T cells. T cell proliferation and expansion were assesse
representative experiment shown on the left.
(E) Left: GM-DCs and GM-Macs were incubated with OVA protein and co-culture
were assessed by flow cytometry after 3 days. Right: GM-DCs and GM-Macs we
washing, and co-culturing with CFSE-labeled naive CD8+ OT-I T cells. T cell prolife
bar graph are mean ± SD of triplicate wells for the representative experiment show
(F) The indicated number of GM-DCs and GM-Macs were pulsed with OVA257-264
B16-OVA tumor cells. Data depict frequency of OVA-specific CD8+ T cells in b
the mean.
Data are representative of two to three experiments. See also Figures S2 and S3tions (Figure 7D). Because those macrophage populations are
derived from embryonic precursors whereas GM-Macs originate
from monocytes, we separately evaluated the relationship of the
GM-Macs to monocytes, monocyte-derived DCs, and mono-
cyte-derived macrophages found in the dermis (McGovern
et al., 2014; Tamoutounour et al., 2013). We found that GM-
Macs clustered together with both dermal monocyte-derived
DCs and macrophages, separately from blood or extravasated
Ly6Chi monocytes (Figure S7). However, GM-Macs occupied a
branch of their own, distinct from all recently described dermal
monocyte-derived cell subtypes. The fact that GM-Macs do
not correspond to a knownmacrophage population probably re-
flects recent findings that the identity of macrophages is largely
imprinted by the microenvironment irrespective of monocytic or
embryonic origin (Gosselin et al., 2014; Lavin et al., 2014). Mac-
rophages grown in culture are therefore unlikely to ever mimic
any one tissue macrophage subtype. We conclude that GM-
DCs and GM-Macs are discrete in-vitro-generated populations
of mononuclear phagocytes that resemble but are distinct from
DCs and macrophages found in vivo.
DISCUSSION
GM-CSF-derived BMDCs have been used as a model to study
DC biology in countless studies. Although the cellular heteroge-
neity in GM-CSF cultures has been appreciated from the
beginning (Inaba et al., 1992), it has generally been thought
that non-DCs can be eliminated by early washing steps, discard-
ing highly adherent cells and enriching or sorting for CD11c+
cells. With some exceptions (Gao et al., 2013), the underlying
assumption has been that the CD11c+ cells obtained in this
manner constitute pure DC populations and that any heteroge-
neity in phenotype and function is a result of ‘‘spontaneous’’
maturation of the cells in culture (Gallucci et al., 1999; Jiang
et al., 2007). Here, we demonstrate that this assumption is incor-
rect and that the CD11c+MHCII+ fraction of GM-CSF cultures
comprises at least two cell types that by ontogenetic and gene
expression criteria correspond to monocyte-derived macro-
phages and CDP-derived DCs. Notably, both undergo matura-
tion in response to LPS but respond differentially to the stimulus
and display distinct functional properties. This hitherto unappre-
ciated heterogeneity of CD11c+MHCII+ cells fromGM-CSF bone
marrow cultures complicates the interpretation of studies thatn
n of inflammatory cytokines and chemokines in the supernatant was measured
. Chemotaxis to CCL2 and CCL21 was measured over a 2 hr period.
protein or OVA323-339 peptide with or without LPS and co-cultured with CFSE-
d after 5 days. Data in the bar graph are mean ± SD of triplicate wells for the
d with CFSE-labeled naive CD8+ OT-I T cells. T cell proliferation and activation
re incubated with or without LPS followed by pulsing with OVA257-264 peptide,
ration and activation were assessed by flow cytometry after 3 days. Data in the
n at left. Dot plots are for data obtained with APCs pulsed with 0.1 nM peptide.
peptide and infused intravenously into mice, which were then challenged with
lood and rejection of B16-OVA lung pseudo-metastases. The bar represents
.
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Figure 6. LPS Stimulation Does Not Lead to Convergence of Gene Expression Profiles of GM-DCs and GM-Macs
(A) Expression of transcripts corresponding to the Immgen signatures for macrophages and DCs. Data are expressed as a log2 difference of expression in GM-
Macs relative to GM-DCs and are the average of triplicate samples.
(B) Total GM-CSF BM cultures were given no stimulus or 100 ng/ml of LPS overnight. Expression of select maturation markers was analyzed by flow cytometry.
(C) Heat map of gene expression for select LPS-responsive genes and markers of maturation, comparing unstimulated or LPS-stimulated sorted GM-Macs and
GM-DCs populations. Individual replicates are shown.
(D) Principal-component analysis of all genes expressed in GM-Macs and GM-DCs stimulated or not with 10 ng/ml of LPS for 4 hr. Each dot of the same color
corresponds to a replicate sample.
(legend continued on next page)
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have rested on the assumption that they represent a single
cell type.
Although the ontogeny of BMDCs has not, until now, been sys-
tematically dissected, it has often been suspected that GM-
CSF-derived BMDCs might be of monocytic origin based on
the analysis of the expansion of Ly6C+ monocytes in GM-CSF
cultures (Mayer et al., 2014; Sallusto and Lanzavecchia, 1994;
Xu et al., 2007). Moreover, because GM-CSF in some in vivo set-
tings of inflammation triggers the differentiation of monocytes
into CD11c+MHCII+ cells (Naik et al., 2006), it has been thought
that GM-CSF-derived BMDCs might be the in vitro equivalent of
‘‘monocyte-derived DCs,’’ elicited in vivo by infection or inflam-
mation (Serbina et al., 2003). Here, we confirm that monocyte-
committed precursors expand vigorously in culture and can
give rise to CD11c+MHCIIhi cells. However, we also show that
the latter can arise from the expansion and differentiation of
DC-restricted precursors. These results highlight a previously
unappreciated ability of CDPs to expand in GM-CSF cultures
and give rise to cells that express CD135, which we term GM-
DCs and constitute bona fide DCs by ontogenetic criteria.
The frequency of GM-DCs and GM-Macs in GM-CSF cultures
is likely to vary from laboratory to laboratory or even, over time,
within a single laboratory based on such factors as variations in
culture medium, batch of fetal calf serum, batch and concentra-
tion of GM-CSF, tissue culture plastic, or experimental tech-
nique. For example, some investigators dispense with the
original step of washing away non-adherent cells (Lutz et al.,
1999), and others utilize IL-4 in addition to GM-CSF or employ
different culture lengths, which might differentially affect output
from different progenitors that require growth factors produced
by other cells developing within the culture. It is therefore
possible that some investigators have historically used cultures
from which GM-Macs are largely absent. On the other hand,
others have reported a very high proportion of CD11c+ cells
that express CD115 and CD14 in GM-CSF cultures, which prob-
ably corresponds to the GM-Macs characterized here (Mayer
et al., 2014). Once one accepts that CD11c+MHCII+ BMDCs
might be heterogeneous, it becomes important to ensure that
this does not impact experimental conclusions. In this regard,
our finding that LPS-driven induction of maturation genes is
greater in GM-DCs while that of interferon-stimulated genes is
higher in GM-Macs bears on the interpretation of recent anal-
ysis of the expression of the same sets of genes after single-
cell RNA sequencing of LPS-stimulated BMDCs (Shalek et al.,
2013). In retrospect, the notable cell-to-cell variations in DC re-
sponses to stimulation found in those studies (Shalek et al.,
2013, 2014) might be in part attributable to differential sampling
and sequencing of GM-DCs versus GM-Macs. It might therefore
be safer to employ DC culture methods that rely on Flt3L-
dependent differentiation of CDPs and preDCs (Naik et al.,
2007), although those can also lead to the growth of CD115+(E) Same as (D) but analyzing only DC signature genes (Immgen).
(F) Same as (D) but analyzing only macrophage signature genes (Immgen).
(G) Venn diagram of genes differentially up- or downregulated byGM-Macs or GM
each region is indicated and examples of genes uniquely induced by LPS in GM
(H) Heat map of selected transcripts in three independent samples of LPS-st
experiments.
See also Figures S4–S7.cells that might constitute monocyte progeny (Mayer et al.,
2014).
In addition to the CD135+ and CD115+ cells that we define as
GM-DCs and GM-Macs, respectively, the CD11c+MHCII+ frac-
tion of GM-CSF cultures comprises a large fraction of ‘‘DN’’ cells
that do not express CD115 or CD135. Our precursor differentia-
tion analysis suggests that GM-DN cells are ontogenetically
heterogeneous. Nevertheless, they present similar functional
properties to GM-DCs and it is interesting to note that they
generate a large proportion of CD135+ GM-DCs upon re-culture.
It is therefore tempting to conclude that DN cells predominantly
comprise a population of GM-DCs that are at an earlier stage of
differentiation and derive fromCDPs. If this is the case, for exper-
imental purposes, it might be sufficient to discriminate CD11c+
MHCII+ BMDCs on the basis of CD115 expression, increasing
GM-DC yield and simplifying purification. Yet, it is important to
note that cMoP and monocyte progeny can nevertheless be
found in the DN gate. Therefore, when maximum homogeneity
is desired, we would advocate including CD135 expression as
an additional stringency criterion to identify GM-DCs.
In summary, we demonstrate a previously unappreciated het-
erogeneity in CD11c+MHCII+ GM-CSF-derived ‘‘BMDCs’’ and
show that some features of DC maturation might equally apply
to certain types of macrophages. In this regard, it will be impor-
tant to assess in further studies whether macrophages might
stimulate certain types of T cell response in some instances
(Gao et al., 2013). Our data add to the notion that traditional ap-
proaches to define mononuclear phagocyte populations based
on phenotype and function need to be revised to take into ac-
count ontogeny and gene expression patterns. Refinement of
in vitro DC culture systems will inevitably lead to a better under-
standing of the function of DCs and macrophages and has impli-
cations for the design of cell-based vaccines for use in humans.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J, B6.SJL, Clec9acre/creRosaWT/EYFP, OT-I3 Rag1/, and OT-II mice
were bred at the London Research Institute in specific-pathogen-free condi-
tions. All experiments were performed in accordance with national and institu-
tional guidelines for animal care and were approved by the London Research
Institute Animal Ethics Committee and by the Home Office, UK.
GM-CSF Cultures
10 3 106 bone marrow cells per well were cultured in tissue-culture-treated
6-well plates in 4 ml of complete medium (RPMI 1640 supplemented with
glutamine, penicillin, streptomycin, 2-mercaptoethanol [all from Invitrogen]),
10% heat-inactivated fetal calf serum (Source BioScience), and GM-CSF
(20 ng/ml, Peprotech). Half of the medium was removed at day 2 and new
medium supplemented with GM-CSF (23, 40 ng/ml) and warmed at 37C
was added. The culture medium was entirely discarded at day 3 and replaced
by fresh warmed medium with GM-CSF (20 ng/ml). For some experiments,
5 ng/ml of IL-4 (Peprotech) was added together with GM-CSF and maintained-DCs in response to LPS, averaged from triplicate samples. Number of genes in
-Macs or GM-DCs are shown.
imulated GM-Macs and GM-DCs. Data are pooled from three independent
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Figure 7. Correlation of GM-DCs and GM-Macs to In Vivo Mononuclear Phagocyte Subsets
(A) Hierarchical clustering of triplicate samples of unstimulated (freshly sorted [GM-DCs] or subsequently cultured without LPS [GM-DCs no LPS]) or LPS-
stimulated GM-DCs (GM-DCs + LPS) and replicates of DC subsets deposited in the Immgen database. The 20% of genes with the most variable expression were
used for the analysis.
(B) Population clustering and heat map of relative transcript value for migratory DC signature genes in unstimulated (freshly sorted [GM-DCs] or subsequently
cultured without LPS [GM-DCs no LPS]) or LPS-stimulated GM-DCs (GM-DCs + LPS) compared to murine DC populations from the Immgen database.
(C) Hierarchical clustering of triplicate samples of unstimulated (freshly sorted [GM-DCs] or subsequently cultured without LPS [GM-DCs no LPS]) or LPS-
stimulated GM-Macs (GM-Macs + LPS) and replicates of macrophage subsets deposited in the Immgen database. The 20% of genes with the most variable
expression were used for the analysis.
(D) Population clustering and heatmap of relative transcript value for alveolar, peritoneal, or red pulp splenic macrophage signature genes in unstimulated (freshly
sorted [GM-DCs] or subsequently cultured without LPS [GM-DCs no LPS]) or LPS-stimulated GM-Macs (GM-Macs + LPS) compared to murine macrophage
populations from the Immgen database. Data are pooled from three independent experiments.
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at that concentration throughout medium changes. On day 6, non-adherent
cells in the culture supernatant and loosely adherent cells harvested by gentle
washing with PBS were pooled and used as the starting source of material for
most experiments.
Flow Cytometry Analysis
Cells were stained in ice-cold PBS containing FCS (2%) and EDTA (2 mM)
using appropriate antibody-fluorophore conjugates. Multiparameter analysis
was performed on a Fortessa analyzer (BD Biosciences) and analyzed with
FlowJo software (Tree Star). The following antibodies were purchased from
BD Bioscience: anti-CD8a (clone 53-6.8), anti-Ly6c (clone AL-21), anti-
CD49b/Pan-NK cells (clone DX5), anti-CD45.1 (clone A20), anti-CD3ε (clone
145-2C11), anti-CD4 (clone RMA4.5), anti-CD16/32 (clone 2.4G2; Fc block),
anti-B220 (clone RA3-6B2), anti-CD40 (clone 3/23), anti-SIRPa (clone P84),
anti-CD25 (clone PC61), anti-CD24 (clone M1/69), and anti-CD62L (clone
MEL-14). The following antibodies were purchased from Biolegend: anti-F4/
80 (clone C1:A3-1), CD11c (clone N418), anti-CD64 (clone X5-4/7.1), anti-
CD86 (GL-1), anti-Gr-1 (clone RB-8C5), anti-CD117 (clone 2B8), anti-CD135
(clone A2F10), anti-CD205 (clone NLDC-145), anti-Ter119 (clone TER119),
and anti-CD64 (clone X54-5/7.1). The following antibodies were purchased
from eBioscience: anti-CD45.1 (clone A20), anti-CD45.2 (clone 104), anti-
MHCII I-A/I-E (cloneM5/114.15.2), anti-CD11b (cloneM1/70), anti-Ly6G (clone
RB6-8C5), anti-CD115 (clone AFS98), anti-CD44 (clone IM7), anti-PDL2 (clone
TY25), anti-IRF4 (clone 3E4), anti-CD14 (clone Sa2-8), and anti-CCR7
(clone 4B12). Anti-MerTK (BAF591) was purchased from R&D System. Anti-
DNGR-1 (clone 1F6) (Sancho et al., 2008) was produced in-house. Corre-
sponding isotype-matched irrelevant specificity controls were purchased
from BD, Biolegend, and eBioscience. H-2Kb/SIINFEKL pentamers were pur-
chased from Proimmune. Prior to acquisition, cells were resuspended in PBS/
FCS 2%/EDTA (2mM) solution with 1 mg/ml of DAPI to exclude dead cells. Live
cell counts were calculated from the acquisition of a fixed number of 10-mm
latex beads (Beckman Coulter) mixed with a known volume of unstained cell
suspension. For intracellular staining, cells were fixed and permeabilized using
the CytoFix/Cytoperm kit (BD).
Cell Sorting
Cells were sorted on a BD FACS Aria (BD Biosciences). For sorting of progen-
itors, total BM cells were isolated and lineage-negative cells were enriched
using magnetic beads. In brief, cells were incubated with Fc-block (BD Biosci-
ences) for 10 min, stained with biotin conjugated antibodies against lineage
markers (see below), and washed before incubation with anti-biotin beads
and enrichment on LD columns (both Miltenyi Biotec). The flow-through frac-
tion was stained with antibodies (see below) and FACS sorted to achieve 99%
purity. Dead cells were excluded via DAPI.
Lineagemarkers for MDPs, cMoPs, and CDPswere CD8, CD4, B220, CD19,
DX5, Ter119, Ly6G, CD11c, and MHCII. Gating criteria were as follows: for
MDPs: Lin–, CD115+, CD117hi, CD135+, DNGR-1–, Ly6C–, CD11b–; for cMoPs:
Lin–, CD115+, CD117hi, Ly6C+, CD11b–, CD135–, DNGR-1–; for CDPs: Lin–,
CD115+, DNGR-1+, CD117lo; and for CDPs from Clec9acre/creRosaWT/EYFP
mice: Lin–, YFP+.
Lineage markers for monocytes were CD8, CD4, B220, CD19, DX5, Ter119,
and Ly6G. Gating criteria were as follows: for monocytes Ly6C+: Lin–, CD115+,
CD11b+, Ly6C+, CD117–, DNGR-1–; for monocytes Ly6C-: Lin–, CD115+,
CD11b+, Ly6C–, CD117–, DNGR-1–.
For sorting GM-DCs and GM-Macs, cultures pooled from at least three mice
were harvested at day 6 and stained with anti-MHCII, -CD11c, -CD11b,
-CD135, -CD115, -MerTK and sorted according to the gating strategy de-
picted in Figure 3C. Dead cells were excluded via DAPI.
In Vitro T Cell Assays
OT-II T Cells
CD4+ T cells from spleens and lymph nodes of OT-II mice were enriched by
magnetic separation using Dynal mouse CD4 negative isolation kit, according
to manufacturer’s instructions. Enriched CD4+ T cells were then stained with
anti-CD4, anti-CD44, and anti-CD62L antibodies and naive OT-II cells were
FACS sorted to achieve 99% purity (CD4+CD44CD62L+). Sorted cells were
labeled with CFSE at 37C for 10 min, washed, and counted before culture
with APCs.OT-I T Cells
CD8+ T cells from spleens and lymph nodes of OT-I 3 Rag1/ mice were
purified from single-cell suspension by magnetic separation on LS columns
(Miltenyi) after labeling with PE-conjugated anti-CD8 antibody and anti-PE
microbeads (Miltenyi) according to the manufacturer’s instructions. Enriched
cells were labeled with CFSE at 37C for 10 min, washed, and counted before
culture with APCs.
Stimulation
Sorted GM-DCs, GM-DN cells, or GM-Macs (gating strategy in Figure 3C)
were incubated in 96-well round-bottom tissue culture plates. For OT-II stim-
ulation, GM-DCs, GM-DN cells, or GM-Macs were incubated with endotoxin-
free OVA protein (10 or 20 mg/ml) or OVA323-339 peptide (10 mM) in the presence
or absence of 100 ng/ml of LPS and co-culturedwith naive CFSE-labeled OT-II
T cell. For OT-I stimulation, GM-DCs, GM-DN cells, and GM-Macs were incu-
bated with endotoxin-free OVA protein (150 mg/ml) or were pre-treated or not
with 10 ng/ml of LPS for 2 hr and pulsed for 20 min with various concentrations
of OVA257-264 peptide (0.1, 1, or 10 nM) before washing. 50,000 GM-DCs, GM-
DN cells, or GM-Macs were incubated with 50,000 T cells. T cell proliferation
and activation was assessed by flow cytometry after 3 days for OT-I T cells and
after 5 days for OT-II T cells.
To assess OVA uptake, total non-adherent and loosely adherent cells from
GM-CSF cultures were collected at day 6 and 105 cells were plated in
96-well round-bottom plates. The next day, cells were incubated at 4C or
37C with OVA-Alexa647 (Molecular Probes) for 1 hr. Cells were then stained
with anti-CD11c, -MHCII, -CD11b, -CD115, -MerTK, -CD135 and presence of
Alexa647 signal was analyzed by flow cytometry in GM-DCs or GM-Macs
identified according to the strategy depicted in Figure 3C.
In Vivo CTL Priming
Sorted GM-DCs and GM-Macs (gating strategy Figure 3C) were incubated in
complete RPMI-1640 medium with 100 nM of OVA257-264 peptide for 30 min.
Cells were washed extensively in PBS and injected intravenously into the tail
vein of C57BL/6 mice. H-2Kb/SIINFEKL MHC pentamers were used for the
detection of OVA-specific CD8+ T cells in the blood 7 days after immunization.
On the same day (day 7), mice were challenged intravenously with OVA-
expressing B16 melanoma cells (2.5 3 105 mouse). Mice were sacrificed
18 days after tumor challenge (day 25) and tumor burden was assessed by
counting lung foci.
Microarrays and Gene Expression Analysis
GM-DCs and GM-Macs were sorted according to the gating strategy depicted
in Figure 3C to achieve 99% purity. For LPS stimulation, sorted GM-DCs and
GM-Macs were cultured with or without 10 ng/ml of LPS for 4 hr in complete
medium, before further processing. For each population, total RNA was ex-
tracted with RNeasy Micro- or Minikit (QIAGEN). RNA was hybridized on the
Affymetrix Mouse Gene 1.0 ST array according to the manufacturer’s instruc-
tions. Each analysis was performed in triplicate using independently sorted
cells prepared from independent cultures, each started with BM pooled
from at least three mice. Data were analyzed with Bioconductor 2.13 (http://
www.bioconductor.org) running on R 3.0.2 (available from http://www.
R-project.org). Probeset expression measures were calculated with the Affy-
metrix package’s Robust Multichip Average (RMA) default method. Differen-
tially expressed genes were assessed between samples using an empirical
Bayes t test (limma package). p values were adjusted for multiple testing by
the Benjamini-Hochberg method. Any probe sets that exhibited an adjusted
p value of 0.05 were called differentially expressed. Two-dimensional hierar-
chical clustering of expression data using DC and macrophage signature
genes obtained from Immgen (Gautier et al., 2012; Miller et al., 2012) was car-
ried out using a 1  Pearson correlation distance matrix and average linkage
clustering. Genes were clustered using a Euclidean distance matrix. For
heat map analysis, colors indicate the expression value relative to the mean
expression value per gene in the dataset. Red indicates upregulation and
blue indicates downregulation relative to mean value.
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